Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Down's syndrome and atherosclerosis.

S Ylä-Herttuala1, J Luoma, T Nikkari

  • 1Department of Biomedical Sciences, University of Tampere, Finland.

Atherosclerosis
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Scientific reports·2025
Same author

BMP2 gene transfer induces pericardial effusion and inflammatory response in the ischemic porcine myocardium.

Frontiers in cardiovascular medicine·2023
Same author

SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space.

Scientific reports·2023
Same author

Decreased Gray-White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea.

The journal of prevention of Alzheimer's disease·2022
Same author

Gene therapy for ischaemic heart disease and heart failure.

Journal of internal medicine·2021
Same author

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.

Angiogenesis·2020
Same journal

Methodological and clinical considerations in a Japanese cohort study of familial hypercholesterolemia and stroke-authors' reply.

Atherosclerosis·2026
Same journal

Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia.

Atherosclerosis·2026
Same journal

Causal insights of modifiable cardiovascular risk factors for dementia risk - potential for efficient prevention and improved brain health.

Atherosclerosis·2026
Same journal

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same journal

Earliest age to detect lifetime cardiometabolic health stratification in children.

Atherosclerosis·2026
Same journal

Sympathetic neurons exacerbate atherosclerosis by modulating macrophage function via the NPY/Y1R axis.

Atherosclerosis·2026
See all related articles

Patients with Down syndrome exhibit milder coronary artery atherosclerosis. Their arteries showed fewer raised lesions and less calcium compared to control groups, suggesting a protective effect.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Pathology

Background:

  • Down syndrome (also known as Trisomy 21) has been anecdotally linked to reduced atherosclerosis.
  • Previous necropsy studies have yielded contradictory findings regarding cardiovascular health in Down syndrome patients.

Purpose of the Study:

  • To investigate and compare the prevalence and severity of coronary artery atherosclerosis in individuals with Down syndrome versus control groups.
  • To ascertain if Down syndrome confers protection against the development of atherosclerosis.

Main Methods:

  • Macroscopic inspection of opened left coronary arteries.
  • Biochemical analysis of the intima-media layer of coronary arteries.
  • Comparison between Down syndrome patients, institutionalized mentally retarded patients, and normal free-living subjects.

Related Experiment Videos

Main Results:

  • Coronary arteries from Down syndrome patients had a significantly lower percentage of raised lesions.
  • Lower levels of calcium were detected in the coronary arteries of Down syndrome patients.
  • Atherosclerosis was present but demonstrably milder in Down syndrome patients compared to both control groups.

Conclusions:

  • Individuals with Down syndrome do not exhibit complete absence of coronary atherosclerosis.
  • Down syndrome appears to be associated with a milder form of atherosclerosis compared to age-matched controls.
  • Further research is warranted to elucidate the mechanisms behind this observed protective effect.